Virtual Reality Home Rehabilitation After Stroke or Parkinson's Disease
Tests virtual reality rehabilitation at home in adults with stroke or Parkinson's disease.
Plain-language title generated from the registry record
Registry title: Motor and Cognitive Telerehabilitation in a Virtual Environment in Patients With Post-stroke Sequelae and Parkinson's Disease
Key facts
- Where
- Bologna, ItalySee the site
Where in Italy
- IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of BolognaBologna, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Azienda Usl di Bologna
- Trial code
- NCT07582497
- Record updated
- 14 May 2026
- Original description
The goal of this interventional pilot trial is to evaluate whether a telerehabilitation protocol based on immersive virtual reality (VR) is effective and feasible for the recovery of cognitive and/or motor functions in patients with sequelae of ischemic or hemorrhagic stroke or with Parkinson's disease.Read full original descriptionShow less
Telerehabilitation in a Virtual Environment for Sensorimotor and Cognitive Recovery in Patients With Post-stroke Sequelae and Parkinson's Disease: a Pilot Study
The goal of this interventional pilot trial is to evaluate whether a telerehabilitation protocol based on immersive virtual reality (VR) is effective and feasible for the recovery of cognitive and/or motor functions in patients with sequelae of ischemic or hemorrhagic stroke or with Parkinson's disease.
The main questions it aims to answer are:
* Does the VR-based telerehabilitation protocol improve cognitive and/or motor outcomes compared to conventional rehabilitation? * Is the protocol feasible, defined as ≥80% adherence among participants? Is the system acceptable and user-friendly from the patient's perspective? Researchers will compare an interventional arm receiving telerehabilitation via an immersive VR home kit with a control arm receiving conventional rehabilitation according to standard clinical practice. Both groups will receive the same number of sessions, with the same duration and weekly frequency. Outcomes will be assessed at baseline (T0), after 4 weeks of treatment (T1), and at 3-month follow-up (T2).
Inclusion: Age >18 years old, both sex; stroke or Parkinson diagnosis > or = 2 months; upper limb impairment; informed consent signed.
Exclusion: important cognitive impairment; psychiatric, neurological, or internal medicine comorbidities; ongoing clinical instability; severe rigidity or hypertonia; severe visual deficit; pregnancy women.